Viewing Study NCT00436605


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2025-12-26 @ 2:04 AM
Study NCT ID: NCT00436605
Status: COMPLETED
Last Update Posted: 2014-05-15
First Post: 2007-02-15
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma
Sponsor: National Cancer Institute (NCI)
Organization: